SCHEMBL12499863

SCHEMBL12499863

CC/C(=C\c1ccc([N+](=O)[O-])c(Br)c1)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.41
▸ MAPT P10636 3/20 0.41
▸ HPGD P15428 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ TBXAS1 P24557 2/20 0.39
▸ DTYMK P23919 1/20 0.38
▸ ABL1 P00519 3/20 0.38
▸ BCR P11274 3/20 0.38
▸ EGFR P00533 1/20 0.38
▸ HCAR3 P49019 2/20 0.37
▸ MEN1 O00255 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12499866 1.00 ALDH1A1 (0.41) ALDH1A1MAPTHPGDKDM4ELMNA
SCHEMBL12499859 1.00 ALDH1A1 (0.41) ALDH1A1MAPTHPGDKDM4ELMNA
SCHEMBL9515290 0.81 TBXAS1 (0.48) MAPTLMNACYP3A4CYP2C9RECQL
SCHEMBL9515296 0.81 TBXAS1 (0.48) MAPTLMNACYP3A4CYP2C9RECQL
SCHEMBL2392661 0.79 KMT2A (0.47) ALDH1A1TBXAS1EGFRMEN1KMT2A
SCHEMBL2394174 0.77 DPEP1 (0.49) TDP1TBXAS1NPC1PSEN1PSEN2
SCHEMBL1907796 0.77 DPEP1 (0.49) TDP1TBXAS1NPC1PSEN1PSEN2
SCHEMBL7936230 0.77 MAPT (0.39) ALDH1A1MAPTHPGDKDM4ELMNA
Acrylic Acid SCHEMBL30268583 0.77 PSEN1 (0.42) ALDH1A1MAPTHPGDKDM4ELMNA
SCHEMBL275826 0.77 ALDH1A1 (0.50) ALDH1A1MAPTKDM4ERECQLTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9765054-B2 Histone deacetylase inhibitors and compositions and methods of use thereof CHDI FOUNDATION, INC. (US) 2017-09-19 — — US disclosed
US-20140163009-A1 HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF CHDI Foundation (US) 2014-06-12 — — US disclosed
EP-2667709-A1 HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF CHDI Foundation, Inc. (US) 2013-12-04 — — EP disclosed
WO-2012103008-A1 HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF CHDI FOUNDATION, INC. (US) 2012-08-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140163009-A1 HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF HDAC1, HDAC7, HDAC5 ALDH1A1 559/4885MAPT 3029/4885HPGD 221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback